Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Pulikkan JA, Madera D, Xue L, Bradley P, Landrette SF, Kuo YH, Abbas S, Zhu LJ, Valk P, Castilla LH. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood. 2012 Jul 26; 120(4):868-79.
-
Amino Acid Sequence
-
Animals
-
Blotting, Western
-
Bone Marrow
-
Bone Marrow Transplantation
-
Cell Cycle
-
Cell Proliferation
-
Chromosomes, Human, Pair 21
-
Chromosomes, Human, Pair 8
-
Core Binding Factor Alpha 2 Subunit
-
Humans
-
Immunoenzyme Techniques
-
Leukemia, Myeloid, Acute
-
Mice
-
Molecular Sequence Data
-
Oncogene Proteins, Fusion
-
Phosphatidylinositol 3-Kinases
-
Proto-Oncogene Proteins c-akt
-
Real-Time Polymerase Chain Reaction
-
Receptors, Thrombopoietin
-
Reverse Transcriptase Polymerase Chain Reaction
-
RNA, Messenger
-
RUNX1 Translocation Partner 1 Protein
-
Signal Transduction
-
Survival Rate
-
Thrombopoietin
-
Translocation, Genetic
-
Tumor Cells, Cultured